These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Fluorine and chlorine substituted adamantyl-urea as molecular tools for inhibition of human soluble epoxide hydrolase with picomolar efficacy. Burmistrov VV; Morisseau C; Danilov DV; Gladkikh BP; D'yachenko VS; Zefirov NA; Zefirova ON; Butov GM; Hammock BD J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2274797. PubMed ID: 37975322 [TBL] [Abstract][Full Text] [Related]
10. Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors. Codony S; Valverde E; Leiva R; Brea J; Isabel Loza M; Morisseau C; Hammock BD; Vázquez S Bioorg Med Chem; 2019 Oct; 27(20):115078. PubMed ID: 31488357 [TBL] [Abstract][Full Text] [Related]
11. Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels. Olearczyk JJ; Field MB; Kim IH; Morisseau C; Hammock BD; Imig JD J Pharmacol Exp Ther; 2006 Sep; 318(3):1307-14. PubMed ID: 16772540 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and Properties of 1,3-Disubstituted Ureas Containing (Adamantan-1-yl)(phenyl)methyl Fragment Based on One-Pot Direct Adamantane Moiety Inclusion. D'yachenko V; Danilov D; Kuznetsov Y; Moiseev S; Mokhov V; Burmistrov V; Butov G Molecules; 2023 Apr; 28(8):. PubMed ID: 37110811 [TBL] [Abstract][Full Text] [Related]
13. Imidazolidine-2,4,5- and pirimidine-2,4,6-triones - New primary pharmacophore for soluble epoxide hydrolase inhibitors with enhanced water solubility. Burmistrov V; Morisseau C; D'yachenko V; Karlov D; Butov GM; Hammock BD Bioorg Med Chem Lett; 2020 Feb; 30(3):126908. PubMed ID: 31870649 [TBL] [Abstract][Full Text] [Related]
14. The 5-substituted piperazine as a novel secondary pharmacophore greatly improving the physical properties of urea-based inhibitors of soluble epoxide hydrolase. Li HY; Jin Y; Morisseau C; Hammock BD; Long YQ Bioorg Med Chem; 2006 Oct; 14(19):6586-92. PubMed ID: 16784862 [TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase. Kim IH; Lee IH; Nishiwaki H; Hammock BD; Nishi K Bioorg Med Chem; 2014 Feb; 22(3):1163-75. PubMed ID: 24433964 [TBL] [Abstract][Full Text] [Related]
16. Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility. Kim IH; Heirtzler FR; Morisseau C; Nishi K; Tsai HJ; Hammock BD J Med Chem; 2005 May; 48(10):3621-9. PubMed ID: 15887969 [TBL] [Abstract][Full Text] [Related]
17. Ureas derived from camphor and fenchone reveal enantiomeric preference of human soluble epoxide hydrolase. Burmistrov V; Morisseau C; Pitushkin D; Fayzullin RR; Karlov D; Vernigora A; Kuznetsov Y; Abbas SMH; Butov GM; Hammock BD Results Chem; 2022 Jan; 4():. PubMed ID: 37601415 [TBL] [Abstract][Full Text] [Related]